Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the Smoothened receptor shows promise for treating certain cancers.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

The study found potential new DNA patterns in fertility genes, but further testing is needed.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Mitotane changes steroid breakdown, affecting cortisol availability.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Nonhuman primates are valuable in research but their natural health variations can complicate study results.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

PCOS symptoms can improve with specific treatments for pituitary adenomas.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

CRABP2 helps increase the growth of cells important for hair growth by activating a specific growth pathway.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Adrenal tumors in hamsters are rare and hard to diagnose, highlighting the need for better diagnostic tools.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

Targeting lipid metabolism can help treat advanced, resistant cancers.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.